HOME  >  Pipelines

GM102

GM102

Indication : Pancreatic cancer

Development stage : Preparing phase I clinical trial

GM oncolytic virus that is capable of overcoming various challenges of the tumor microenvironment as well as optimizing viral replication in hypoxic solid tumors
  • - Excellent tumor-specific killing effect
  • - Overcomes pancreatic tumor-specific microenvironment
  • - Ameliorates tumor-induced hypoxia
  • - Decreases proliferation and metastasis of tumor cells
TOP